Search all trials

Find therapies in clinical trials near you – page 32

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Registered drugNo placebo

Study of Capivasertib with CDK4/6 Inhibitors and Fulvestrant for Patients with Advanced HR+/HER2- Breast Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Abemaciclib

Contact Research Centre

Hidradenitis

Not recruiting

Investigational

Study to Evaluate the Effectiveness of Spesolimab for Patients with Moderate to Severe Hidradenitis Suppurativa

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Spesolimab

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Registered drugNo placebo

Study on Giredestrant or Tamoxifen for Premenopausal Women with Early ER-Positive, HER2-Negative Breast Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Giredestrant

Contact Research Centre

Myelodysplastic syndrome

Not recruiting

Registered drugNo placebo

Study on Luspatercept and Epoetin Alfa for Treating Anemia in Patients with Low to Intermediate Risk Myelodysplastic Syndromes Needing Blood Transfusions

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Epoetin Alfa

Contact Research Centre

Marginal zone lymphoma+1

Not recruiting

Registered drugNo placebo

Study Comparing Zanubrutinib, Obinutuzumab, and Rituximab with Lenalidomide and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Lenalidomide

Contact Research Centre

Breast cancer metastatic+1

Not recruiting

InvestigationalNo placebo

Study of Trastuzumab Deruxtecan for Patients with HER2-Positive Metastatic Breast Cancer Resistant to Trastuzumab, Pertuzumab, and Taxane Treatment

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Trastuzumab Deruxtecan

Contact Research Centre

Isodicentric chromosome 15 syndrome+3

Not recruiting

InvestigationalNo placebo

Study on Long-Term Safety of Soticlestat for Adults and Children with Developmental Epileptic Encephalopathies

InvestigationalNo placebo

Spain

Participants:0–17 years · 18–64 years
Substances:Soticlestat

Contact Research Centre

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Not recruiting

Registered drugNo placebo

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Registered drugNo placebo

Spain

Participants:0–17 years
Substances:Alemtuzumab

Contact Research Centre

HER2 negative breast cancer

Not recruiting

Registered drugNo placebo

Study on Irinotecan for Brain Metastases in Patients with HER2-Negative Breast Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Irinotecan

Contact Research Centre

HIV infection

Not recruiting

Registered drugNo placebo

Study on the Effects of Abacavir Sulfate and Etravirine in Pregnant Women with HIV

Registered drugNo placebo

Spain

Participants:18–64 years
Substances:Abacavir Sulfate

Contact Research Centre

Breast cancer+1

Not recruiting

Registered drugNo placebo

Study of PF-07220060 and Letrozole for Postmenopausal Women with HR-Positive, HER2-Negative Breast Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Letrozole

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study Comparing Lenalidomide, Bortezomib, Dexamethasone, Isatuximab, and Iberdomide for Newly Diagnosed Multiple Myeloma Patients Eligible for Stem Cell Transplant

Registered drugNo placebo

Spain

Participants:18–64 years
Substances:Bortezomib

Contact Research Centre

Find therapies in clinical trials near you – page 32

390 trials match your criteria

Hormone receptor positive HER2 negative breast cancer

Study of Capivasertib with CDK4/6 Inhibitors and Fulvestrant for Patients with Advanced HR+/HER2- Breast Cancer

Hidradenitis

Study to Evaluate the Effectiveness of Spesolimab for Patients with Moderate to Severe Hidradenitis Suppurativa

Hormone receptor positive HER2 negative breast cancer

Study on Giredestrant or Tamoxifen for Premenopausal Women with Early ER-Positive, HER2-Negative Breast Cancer

Myelodysplastic syndrome

Study on Luspatercept and Epoetin Alfa for Treating Anemia in Patients with Low to Intermediate Risk Myelodysplastic Syndromes Needing Blood Transfusions

Marginal zone lymphoma+1

Study Comparing Zanubrutinib, Obinutuzumab, and Rituximab with Lenalidomide and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

Breast cancer metastatic+1

Study of Trastuzumab Deruxtecan for Patients with HER2-Positive Metastatic Breast Cancer Resistant to Trastuzumab, Pertuzumab, and Taxane Treatment

Isodicentric chromosome 15 syndrome+3

Study on Long-Term Safety of Soticlestat for Adults and Children with Developmental Epileptic Encephalopathies

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

HER2 negative breast cancer

Study on Irinotecan for Brain Metastases in Patients with HER2-Negative Breast Cancer

HIV infection

Study on the Effects of Abacavir Sulfate and Etravirine in Pregnant Women with HIV

Breast cancer+1

Study of PF-07220060 and Letrozole for Postmenopausal Women with HR-Positive, HER2-Negative Breast Cancer

Plasma cell myeloma

Study Comparing Lenalidomide, Bortezomib, Dexamethasone, Isatuximab, and Iberdomide for Newly Diagnosed Multiple Myeloma Patients Eligible for Stem Cell Transplant

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.